MANKIND logo

Mankind Pharma Limited

F&O
MANKIND·NSE·
2,372.40 +15.90 (+0.67%)
Market Cap98779.73 Cr
PE Ratio51.20
Volume2,72,967
Day High - Low2384.40 - 2341.20
52W High-Low2674.00 - 1909.70
DocStoX Score
5.5/10
Fair
Fair Value
Sign in to see
ROE
13.10%
Average
P/E
51.20x
Expensive
Debt / Equity
0.34
Moderate
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed

Price performance

NIFTY 200NIFTY 500NIFTY MIDCAP 150
Day2341
2384
52W1910
2674
DocStoX take

Supported by risk (9.4) and momentum (6.5), but held back by valuation (0.0). Risk looks strong at 9.4, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
5.5
/10
Fair
Quality
Solid
ROE 13.1%
Valuation
Expensive
P/E 51.2×
Growth
Steady
Revenue +18.1% 5Y CAGR
Risk
Low risk
D/E 0.34
Momentum
Firm
61% of 52-week range

At a glance

Market Cap
₹98,780 Cr
52W High / Low
₹2674 / ₹1910
Dividend Yield
0.04%
Promoter Holding
72.63%
EPS (TTM)
₹46.34
Book Value
₹395.00

Key highlights

  • Profitable in all of the last 5 years
  • Revenue compounding 18% a year
  • Valuation is weak (0.0/10)
2 Positives1 Watchout

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Healthcare stocks · Pharmaceuticals

MANKIND PHARMA LIMITED peers in Healthcare

Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.